Company Details
Website
Location
- 4400 Biscayne Boulevard, Suite 980 Miami, FL 33137
Founding Date
- 2006
Non-Florida HQ
Company Description
- Founded in 2006 by Prof. Nicholas S. Bodor to further the development and therapeutic potential of his novel Retrometabolic Drug Design and Targeting concepts. Traditionally, development of therapeutics targeted to exploit newly identified pathways results in exceptionally high rates of drug failures, either through lack of effectiveness or unacceptable toxicity. The Retrometabolic Drug Design process provides a means of capitalizing on known pathways and therapeutics to develop novel compounds that have considerably less side-effects and clear paths to approval success. We have utilized this drug design approach to build a substantive portfolio of intellectual property, which we are able to develop through collaborative partnerships to drive these ideas to the market.